健康经济专员--第三页
中美上海施贵宝制药有限公司 Sino-American Shanghai Squibb Pharmaceuticals Ltd.
- 公司规模:500-1000人
- 公司性质:合资(欧美)
- 公司行业:制药/生物工程
职位信息
- 发布日期:2012-11-09
- 工作地点:上海
- 招聘人数:1
- 职位类别:其他
职位描述
Major Responsibilities:
? Routine work for the study operation
? Communicate regularly with the CRO and project manager for 1)assist hospital investigators on kick off meeting; (2) periodic payments; and (3) data lock (time and frequencies);
? Facilitate Publication process
? Support the study operation process inside the company like bidding process, contract preparation
? Scientific support for different TAs
? Paper work on dossier and study
? Scientific information support for all the TAs
? Logistic support, Support the AB meeting and other meetings, Support the routine process
Qualification Requirement:
? Bachelor agree or above, preferred public health or health economic related major
? at least 2 years project management experience in healthcare industry
? excellent communication capability
? good verbal and written English
? good team work spirit, good computer skills
注:此职位为第三方职位。
? Routine work for the study operation
? Communicate regularly with the CRO and project manager for 1)assist hospital investigators on kick off meeting; (2) periodic payments; and (3) data lock (time and frequencies);
? Facilitate Publication process
? Support the study operation process inside the company like bidding process, contract preparation
? Scientific support for different TAs
? Paper work on dossier and study
? Scientific information support for all the TAs
? Logistic support, Support the AB meeting and other meetings, Support the routine process
Qualification Requirement:
? Bachelor agree or above, preferred public health or health economic related major
? at least 2 years project management experience in healthcare industry
? excellent communication capability
? good verbal and written English
? good team work spirit, good computer skills
注:此职位为第三方职位。
公司介绍
百时美施贵宝是一家以“研发并提供创新药物,帮助患者战胜严重疾病”为使命的全球性生物制药公司。
2019年11月20日,百时美施贵宝成功完成了对新基的收购,将双方在领先的科学、创新的药物和优秀的人才等方面的优势合二为一,打造全球领先的生物制药企业。公司在肿瘤、血液、免疫和心血管疾病等领域处于世界前列,并具有丰富的,且具有行业前景的产品管线。
如今,中国已是百时美施贵宝公司全球重要的研发、生产、营销和创新中心之一。我们致力于满足中国未被满足的迫切的重大疾病需求,引领行业发展,开展多元合作,以帮助中国患者战胜严重疾病。
2019年11月20日,百时美施贵宝成功完成了对新基的收购,将双方在领先的科学、创新的药物和优秀的人才等方面的优势合二为一,打造全球领先的生物制药企业。公司在肿瘤、血液、免疫和心血管疾病等领域处于世界前列,并具有丰富的,且具有行业前景的产品管线。
如今,中国已是百时美施贵宝公司全球重要的研发、生产、营销和创新中心之一。我们致力于满足中国未被满足的迫切的重大疾病需求,引领行业发展,开展多元合作,以帮助中国患者战胜严重疾病。
联系方式
- 公司地址:地址:span南京